Did CATB stock beat earnings estimates in the most recent quarter?
Catabasis Pharma (CATB) beat EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:CATB
Past quarterly earnings results for Catabasis Pharma (CATB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2021 | -1.26 | -1.86 | 32.13% | -137.74% | - | - | ||
| Q1 2021 | -1.44 | -0.94 | -53.45% | -188.00% | - | - | ||
| Q4 2020 | -2.64 | -2.26 | -16.59% | - | - | - | ||
| Q3 2020 | -0.56 | -3.12 | 82.06% | - | - | - | ||
| Q2 2020 | -0.53 | -2.78 | 80.97% | - | - | - | ||
| Q1 2020 | -0.50 | -2.51 | 80.07% | - | - | - |
Notes
Catabasis Pharma (CATB) beat EPS estimates and missed revenue estimates in the most recent quarter.